The Global Womens Healthcare Market size is projected to reach USD 17.8 billion by 2024, at a CAGR of 13.2%. The growth of the market is primarily driven by factors such as the growing incidence of chronic health conditions among women, government initiatives to curb population growth, and growing demand for contraceptives to prevent unintended pregnancies. Moreover, the growing focus on R&D by key players for the development of advanced products is also a major factor in driving market growth.
Download PDF Brochure:
Women's Healthcare Market Dynamics
Market Growth Drivers
· Growing Incidence of Chronic Health Conditions Among Women
· Demand for Contraceptives to Prevent Unintended Pregnancies
· Government Initiatives to Curb Population Growth
· Growing Focus on Product R&D
Market Growth Opportunities
· Emerging Markets
· Development of Innovative Technologies
Market Challenges
· Reluctance to Use Contraceptives
· Lack of Access to Quality Care
Global Women's Healthcare Market Segmentation:
By Drug
· EVISTA
· XGEVA
· Prolia
· Mirena
· Zometa
· Reclast/Aclasta
· Minastrin 24 Fe
· NuvaRing
· FORTEO
· Premarin
· ACTONEL
· ORTHO TRI-CY LO (28)
By Application
· Hormonal Infertility
· Postmenopausal Osteoporosis
· Endometriosis
· Contraceptives
· Menopause
· Polycystic Ovary Syndrome
· Other Applications
North America accounted for the largest share of the women’s healthcare industry in 2019.
The global women’s healthcare market is segmented into five major regions, namely, North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2018, North America (US and Canada) was the largest and the fastest-growing regional market for women’s healthcare. The major factors supporting market growth include the growing prevalence of PCOS and postmenopausal osteoporosis, increasing median age of first-time pregnancies, and increased healthcare spending in the US and Canada. Also, the high awareness and understanding regarding contraceptives among American women and the easy access to modern contraception as compared to developing countries propel the market growth in this region.
Report Objectives
· To define, describe, and forecast the women’s healthcare market on the basis of drug, application, and region
· To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, opportunities, and challenges)
· To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
· To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
· To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa
· To profile the key players and analyze their market shares and core competencies
· To track and analyze competitive developments such as product launches; partnerships, agreements, & collaborations; expansions & strategic alliances; and acquisitions in the market
· To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy
Request 10% Customization:
Comments